Proteomic liquid biopsy technology may improve early breast cancer detection, guide targeted therapy selection, and support longitudinal treatment monitoring in oncology care.
Jayant Parthasarathy, PhD
Advertisement
Articles by Jayant Parthasarathy, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
4
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
5